Published online 9 February 2004
Nucleic Acids Research, 2004, Vol. 32, No. 3 893-901
© 2004 Oxford University Press
A library of siRNA duplexes targeting the phosphoinositide 3-kinase pathway: determinants of gene silencing for use in cell-based screens
1 Department of Medical Oncology and 2 Department of Biostatistical Sciences, Dana-Farber Cancer Institute and 3 Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA and 4 Dharmacon Inc., Lafayette, CO 80026, USA
*To whom correspondence should be addressed. Tel: +1 617 632 4750; Fax: +1 617 632 5417; Email: william_sellers{at}dfci.harvard.edu
Present address:
Andrew C. Hsieh, Albert Einstein College of Medicine, 1925 Eastchester Road, 28F, Bronx, NY 10461, USA.
Gene silencing through RNA interference (RNAi) has been established as a means of conducting reverse genetic studies. In order to better understand the determinants of short interfering RNA (siRNA) knockdown for use in high-throughput cell-based screens, 148 siRNA duplexes targeting 30 genes within the PI3K pathway were selected and synthesized. The extent of RNA knockdown was measured for 22 genes by quantitative real-time PCR. Analysis of the parameters correlating with effective knockdown showed that (i) duplexes targeting the middle of the coding sequence silenced significantly poorer, (ii) silencing by duplexes targeting the 3'UTR was comparable with duplexes targeting the coding sequence, (iii) pooling of four or five duplexes per gene was remarkably efficient in knocking down gene expression and (iv) among duplexes that achieved a >70% knockdown of the mRNA there were strong nucleotide preferences at specific positions, most notably positions 11 (G or C) and 19 (T) of the siRNA duplex. Finally, in a proof-of-principle pathway-wide cell-based genetic screen, conducted to detect negative genetic regulators of Akt S473 phosphorylation, both known negative regulators of this phosphorylation, PTEN and PDK1, were found. These data help to lay the foundation for genome-wide siRNA screens in mammalian cells.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  X. D. Zhang, P. F. Kuan, M. Ferrer, X. Shu, Y. C. Liu, A. T. Gates, P. Kunapuli, E. M. Stec, M. Xu, S. D. Marine, et al. Hit selection with false discovery rate control in genome-scale RNAi screens Nucleic Acids Res., July 15, 2008; (2008) gkn435v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ichihara, Y. Murakumo, A. Masuda, T. Matsuura, N. Asai, M. Jijiwa, M. Ishida, J. Shinmi, H. Yatsuya, S. Qiao, et al. Thermodynamic instability of siRNA duplex is a prerequisite for dependable prediction of siRNA activities Nucleic Acids Res., September 25, 2007; 35(18): e123 - e123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Dormond, J. C. Madsen, and D. M. Briscoe The Effects of mTOR-Akt Interactions on Anti-apoptotic Signaling in Vascular Endothelial Cells J. Biol. Chem., August 10, 2007; 282(32): 23679 - 23686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Jian, X. Cheng, J. Jiang, S. Deng, F. Hu, and J. Zhang A cDNA-Based Random RNA Interference Library for Functional Genetic Screens in Embryonic Stem Cells Stem Cells, August 1, 2007; 25(8): 1904 - 1912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Rondinone Minireview: Ribonucleic Acid Interference for the Identification of New Targets for the Treatment of Metabolic Diseases Endocrinology, June 1, 2006; 147(6): 2650 - 2656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ren, W. Gong, Q. Xu, X. Zheng, D. Lin, Y. Wang, and T. Li siRecords: an extensive database of mammalian siRNAs with efficacy ratings Bioinformatics, April 15, 2006; 22(8): 1027 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bartz and A. L. Jackson How Will RNAi Facilitate Drug Development? Sci. Signal., August 2, 2005; 2005(295): pe39 - pe39. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Sledz and B. R. G. Williams RNA interference in biology and disease Blood, August 1, 2005; 106(3): 787 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Juliano, V. R. Dixit, H. Kang, T. Y. Kim, Y. Miyamoto, and D. Xu Epigenetic manipulation of gene expression: a toolkit for cell biologists J. Cell Biol., June 20, 2005; 169(6): 847 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. JAGLA, N. AULNER, P. D. KELLY, D. SONG, A. VOLCHUK, A. ZATORSKI, D. SHUM, T. MAYER, D. A. DE ANGELIS, O. OUERFELLI, et al. Sequence characteristics of functional siRNAs RNA, June 1, 2005; 11(6): 864 - 872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. SEYHAN, A. V. VLASSOV, H. ILVES, L. EGRY, R. L. KASPAR, S. A. KAZAKOV, and B. H. JOHNSTON Complete, gene-specific siRNA libraries: Production and expression in mammalian cells RNA, May 1, 2005; 11(5): 837 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Santoyo, J. M. Vaquerizas, and J. Dopazo Highly specific and accurate selection of siRNAs for high-throughput functional assays Bioinformatics, April 15, 2005; 21(8): 1376 - 1382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Qiu, C. M. Adema, and T. Lane A computational study of off-target effects of RNA interference Nucleic Acids Res., March 30, 2005; 33(6): 1834 - 1847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Truss, M. Swat, S. M. Kielbasa, R. Schafer, H. Herzel, and C. Hagemeier HuSiDa--the human siRNA database: an open-access database for published functional siRNA sequences and technical details of efficient transfer into recipient cells Nucleic Acids Res., January 1, 2005; 33(suppl_1): D108 - D111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I Bantounas, L A Phylactou, and J B Uney RNA interference and the use of small interfering RNA to study gene function in mammalian systems J. Mol. Endocrinol., December 1, 2004; 33(3): 545 - 557. [Abstract] [Full Text] [PDF]
|
|